IMMUTEP LIMITED - AMER
2.0500
07-十月-24 14:59:57
15 分钟延时
股票
0.0000
0.00%
今日范围
2.0200 - 2.0900
ISIN
N/A
来源
NASDAQ
-
03 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Receives A$3.6 million R&D Tax Incentive from French Government
24 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
18 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
16 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
20 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
14 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep to Participate in Upcoming Investor Conferences
07 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q4 FY24
31 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer
22 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
17 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
11 7月 2024 17:40:40 条件 Nasdaq GlobeNewswire
-
03 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
25 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
05 6月 2024 05:00:00 条件 Nasdaq GlobeNewswire
-
02 6月 2024 19:38:39 条件 Nasdaq GlobeNewswire
-
Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024
15 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
02 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q3 FY24
29 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
24 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
18 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >